Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer. Issue 3 (September 2016)
- Record Type:
- Journal Article
- Title:
- Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer. Issue 3 (September 2016)
- Main Title:
- Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer
- Authors:
- Leseur, Julie
Roman-Jimenez, Geoffrey
Devillers, Anne
Ospina-Arango, Juan D.
Williaume, Daniele
Castelli, Joel
Terve, Pierre
Lavoue, Vincent
Garin, Etienne
Lejeune, Florence
Acosta, Oscar
De Crevoisier, Renaud - Abstract:
- Abstract: Purpose: To describe the evolution and to assess the predictive value of metabolic parameters with different SUV threshold segmentations calculated from two 18F-FDG-PET/CT, one prior to and the other one during concomitant chemoradiation therapy (CCRT), for locally-advanced cervical cancer (LACC). Material and methods: 53 patients treated for LACC by CCRT underwent FDG-PET/CT before treatment (PET1) and another one at 40 Gy (PET2). The PET analyzed parameters were: maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG). MTVs were automatically segmented using various percentage SUVmax thresholds (30–70%) and fixed SUV thresholds (all voxels with SUV >1–20). The parameters' predictive capabilities for disease-free (DFS) and overall survival (OS) were assessed using the Harrell's C-index ( c ) and Cox regression model. Results: Depending on the SUVmax threshold, the relative decreases in MTV and TLG from PET1 to PET2 were, on average, 65% (range: 63–70%) and 85% (range: 83–86%), respectively. The strongest predictive threshold segmentations were 55% SUVmax in PET1 and 32% in PET2. Significant predictors of DFS in multivariate analysis ( c = 0.82) were MTV1 (55% SUVmax) in PET1 and TLG2 (32% SUVmax) in PET2. MTV1 (55%) was the most significant OS predictor. Conclusions: MTV and TLG calculated with a threshold of 55% SUVmax and 32% SUVmax from pre- and per-treatment PET scans respectively, can be used to predictAbstract: Purpose: To describe the evolution and to assess the predictive value of metabolic parameters with different SUV threshold segmentations calculated from two 18F-FDG-PET/CT, one prior to and the other one during concomitant chemoradiation therapy (CCRT), for locally-advanced cervical cancer (LACC). Material and methods: 53 patients treated for LACC by CCRT underwent FDG-PET/CT before treatment (PET1) and another one at 40 Gy (PET2). The PET analyzed parameters were: maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG). MTVs were automatically segmented using various percentage SUVmax thresholds (30–70%) and fixed SUV thresholds (all voxels with SUV >1–20). The parameters' predictive capabilities for disease-free (DFS) and overall survival (OS) were assessed using the Harrell's C-index ( c ) and Cox regression model. Results: Depending on the SUVmax threshold, the relative decreases in MTV and TLG from PET1 to PET2 were, on average, 65% (range: 63–70%) and 85% (range: 83–86%), respectively. The strongest predictive threshold segmentations were 55% SUVmax in PET1 and 32% in PET2. Significant predictors of DFS in multivariate analysis ( c = 0.82) were MTV1 (55% SUVmax) in PET1 and TLG2 (32% SUVmax) in PET2. MTV1 (55%) was the most significant OS predictor. Conclusions: MTV and TLG calculated with a threshold of 55% SUVmax and 32% SUVmax from pre- and per-treatment PET scans respectively, can be used to predict patient outcome after CCRT for LACC. … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 120:Issue 3(2016:Sep.)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 120:Issue 3(2016:Sep.)
- Issue Display:
- Volume 120, Issue 3 (2016)
- Year:
- 2016
- Volume:
- 120
- Issue:
- 3
- Issue Sort Value:
- 2016-0120-0003-0000
- Page Start:
- 512
- Page End:
- 518
- Publication Date:
- 2016-09
- Subjects:
- Radiotherapy -- 18F-FDG PET -- Cervix cancer -- Prognosis
Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2016.08.008 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1755.xml